| Primary |
| Ill-defined Disorder |
18.2% |
| Pruritus |
13.0% |
| Insomnia |
10.4% |
| Psoriasis |
10.4% |
| Anxiety |
9.1% |
| Urticaria |
7.8% |
| Rhinitis Allergic |
6.5% |
| Hypertension |
3.9% |
| Neurosis |
3.9% |
| Eczema |
2.6% |
| Migraine |
2.6% |
| Anaesthetic Premedication |
1.3% |
| Aneurysm Repair |
1.3% |
| Angina Pectoris |
1.3% |
| Antiallergic Therapy |
1.3% |
| Anxiety Disorder |
1.3% |
| Bipolar Disorder |
1.3% |
| Cerebrovascular Accident |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Convulsion |
1.3% |
|
| Suicide Attempt |
13.5% |
| Completed Suicide |
9.6% |
| Death |
9.6% |
| Drug Eruption |
7.7% |
| Cardio-respiratory Arrest |
5.8% |
| Erythema Multiforme |
5.8% |
| Rash |
5.8% |
| Respiratory Arrest |
5.8% |
| Stevens-johnson Syndrome |
5.8% |
| Acute Generalised Exanthematous Pustulosis |
3.8% |
| Scar |
3.8% |
| Somnolence |
3.8% |
| Suicidal Ideation |
3.8% |
| Urticaria |
3.8% |
| Asthenia |
1.9% |
| Autonomic Nervous System Imbalance |
1.9% |
| Chest Discomfort |
1.9% |
| Drug Ineffective |
1.9% |
| Drug Screen False Positive |
1.9% |
| Drug Withdrawal Convulsions |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
30.9% |
| Cancer Pain |
22.4% |
| Drug Use For Unknown Indication |
16.0% |
| Depression |
5.7% |
| Therapeutic Embolisation |
3.0% |
| Angioedema |
2.5% |
| Premedication |
2.2% |
| Infection |
2.0% |
| Schizophrenia |
2.0% |
| Anaesthesia |
1.7% |
| Anxiety |
1.5% |
| Delirium |
1.5% |
| Ill-defined Disorder |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Bipolar Disorder |
1.0% |
| Contraception |
1.0% |
| Embolism Arterial |
1.0% |
| Smoking Cessation Therapy |
1.0% |
| Blood Cholesterol Increased |
0.7% |
| Breast Cancer |
0.7% |
|
| Overdose |
16.4% |
| Somnolence |
9.1% |
| Pulmonary Embolism |
7.3% |
| Rash |
7.3% |
| Drug Ineffective |
5.5% |
| Thrombocytopenia |
5.5% |
| Cardiac Arrest |
3.6% |
| Completed Suicide |
3.6% |
| Death |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.6% |
| Foetal Heart Rate Abnormal |
3.6% |
| Gamma-glutamyltransferase Increased |
3.6% |
| Hepatitis Fulminant |
3.6% |
| Liver Transplant |
3.6% |
| Sinus Tachycardia |
3.6% |
| Suicide Attempt |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Vomiting |
3.6% |
| Weight Increased |
3.6% |
| Aspiration |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
54.7% |
| Drug Use For Unknown Indication |
6.8% |
| Infection Prophylaxis |
6.6% |
| Prophylaxis |
5.7% |
| Hypertension |
2.7% |
| Hiv Infection |
2.6% |
| Premedication |
2.5% |
| Bone Marrow Conditioning Regimen |
2.4% |
| Prophylaxis Against Graft Versus Host Disease |
2.4% |
| Insomnia |
2.3% |
| Acute Myeloid Leukaemia |
1.7% |
| Pain |
1.5% |
| Depression |
1.3% |
| Pruritus |
1.2% |
| Anxiety |
1.1% |
| Constipation |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Antifungal Prophylaxis |
0.9% |
| Prophylaxis Of Nausea And Vomiting |
0.9% |
| Graft Versus Host Disease |
0.8% |
|
| Pyrexia |
9.6% |
| Vomiting |
9.6% |
| Rash |
6.7% |
| Weight Decreased |
6.7% |
| Renal Failure Acute |
5.3% |
| Staphylococcal Sepsis |
5.3% |
| Toothache |
5.3% |
| Fungal Infection |
4.8% |
| Thrombocytopenia |
4.8% |
| Urinary Tract Infection |
4.8% |
| Urticaria |
4.8% |
| Hemiparesis |
4.3% |
| Thrombosis |
4.3% |
| Type 2 Diabetes Mellitus |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Dyspnoea |
3.4% |
| Vertigo |
3.4% |
| Weight Increased |
3.4% |
| Nausea |
2.9% |
| Syncope Vasovagal |
2.9% |
|
